Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
25
MC Quote, Financials, Valuation and Earnings
Last price:
$60.91
Seasonality move
:
2.97%
Day range:
$59.67 - $61.51
52-week range:
$46.24 - $82.89
Dividend yield:
4.02%
P/E ratio:
34.60x
P/S ratio:
3.90x
P/B ratio:
9.74x
Volume:
5.7M
Avg. volume:
1.1M
1-year change:
6.58%
Market cap:
$4.3B
Revenue:
$1.2B
EPS (TTM):
$1.76
Analysts' Opinion
-
Consensus RatingMoelis & has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 3 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $74.71, Moelis & has an estimated upside of 22.7% from its current price of $60.89.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $63.00 representing -3.47% downside risk from its current price of $60.89.
Fair Value
-
According to the consensus of 8 analysts, Moelis & has 22.7% upside to fair value with a price target of $74.71 per share.
MC vs. S&P 500
-
Over the past 5 trading days, Moelis & has overperformed the S&P 500 by 1.73% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Moelis & does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Moelis & has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Moelis & reported revenues of $438.7M.
Earnings Growth
-
Moelis & has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Moelis & reported earnings per share of $1.15.
Enterprise value:
3.9B
EV / Invested capital:
--
Price / LTM sales:
3.90x
EV / EBIT:
22.69x
EV / Revenue:
3.29x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
9.45x
Price / Operating cash flow:
11.21x
Enterprise value / EBITDA:
21.40x
Gross Profit (TTM):
$364.4M
Return On Assets:
11.78%
Net Income Margin (TTM):
11.39%
Return On Equity:
33.77%
Return On Invested Capital:
33.77%
Operating Margin:
29.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $985.3M | $854.7M | $1.2B | $214.9M | $438.7M | |
| Gross Profit | $367.1M | $140M | $364.4M | $36.4M | $181.6M | |
| Operating Income | $216.1M | -$40.4M | $172.9M | -$9.3M | $131.5M | |
| EBITDA | $224.1M | -$32M | $183.4M | -$7.1M | $134.3M | |
| Diluted EPS | $2.15 | -$0.36 | $1.76 | -$0.08 | $1.15 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $304.5M | $590.6M | $263.9M | $250.9M | $486.9M | |
| Total Assets | $1.2B | $1.6B | $1.2B | $1.2B | $1.4B | |
| Current Liabilities | $555.4M | $885.5M | $565.2M | $601.6M | $676.3M | |
| Total Liabilities | $752M | $1.1B | $757.9M | $817.3M | $899.6M | |
| Total Equity | $444.5M | $478.3M | $458.9M | $362.5M | $479.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $33M | $158.5M | $427.5M | $99.3M | $315.3M | |
| Cash From Investing | -$11.2M | $48.6M | $17.1M | -$15.4M | $3.7M | |
| Cash From Financing | -$326.9M | -$229.2M | -$215.1M | -$46.2M | -$47M | |
| Free Cash Flow | $27M | $141.8M | $415.4M | $94.1M | $313M | |
MC
Sector
Market Cap
$4.3B
$616.2M
Price % of 52-Week High
73.46%
85.86%
Dividend Yield
4.02%
1.99%
Shareholder Yield
3.46%
3.77%
1-Year Price Total Return
6.58%
8.45%
Beta (5-Year)
1.434
0.714
Dividend yield:
4.02%
Annualized payout:
$2.40
Payout ratio:
135.39%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$59.92
200-day SMA
Sell
Level
$67.81
Bollinger Bands (100)
Sell
Level
66.96 - 78.34
Chaikin Money Flow
Buy
Level
41.3M
20-day SMA
Sell
Level
$64.26
Relative Strength Index (RSI14)
Sell
Level
34.42
ADX Line
Sell
Level
40.46
Williams %R
Neutral
Level
-66.9032
50-day SMA
Sell
Level
$71.76
MACD (12, 26)
Sell
Level
-3.83
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
25.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.7597)
Sell
CA Score
(Annual)
Level (-0.3604)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.4675)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
Stock Forecast FAQ
In the current month, MC has received 0 Buy ratings 5 Hold ratings, and 3 Sell ratings. The MC average analyst price target in the past 3 months is $74.71.
-
Where Will Moelis & Stock Be In 1 Year?
According to analysts, the consensus estimate is that Moelis & share price will rise to $74.71 per share over the next 12 months.
-
What Do Analysts Say About Moelis &?
Analysts are divided on their view about Moelis & share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Moelis & is a Buy and believe this share price will drop from its current level to $92.00.
-
What Is Moelis &'s Price Target?
The price target for Moelis & over the next 1-year time period is forecast to be $74.71 according to 8 Wall Street analysts, 0 of them rate the stock a Buy, 3 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is MC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Moelis & is a Hold. 5 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MC?
You can purchase shares of Moelis & via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Moelis & shares.
-
What Is The Moelis & Share Price Today?
Moelis & was last trading at $60.91 per share. This represents the most recent stock quote for Moelis &. Yesterday, Moelis & closed at $60.89 per share.
-
How To Buy Moelis & Stock Online?
In order to purchase Moelis & stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
